Use of nucleoside reverse transcriptase inhibitors (NRTIs) is associated with a significantly lower risk of developing Alzheimer disease (AD), according to findings published in Alzheimer’s & Dementia ...

The global Reverse Transcriptase Enzymes Market is projected to grow from USD 370.3 million in 2025 to USD 517.4 million by 2035, reflecting a compound annual growth rate (CAGR) of 3.4% over the ...